Cell Therapy Manufacturing Market Expected to Achieve US$ 15.6 Billion by 2033 at an Astonishing 14.
The global cell therapy manufacturing market is on the brink of substantial expansion, with a projected value of US$ 4,134.48 million in 2023. This dynamic market is expected to sustain an impressive compound annual growth rate (CAGR) of 14.2% from 2023 to 2033, ultimately culminating in an estimated worth of around...
New York United States Gilead Sciences Inc Route Of Administration Merck Kgaa Greater New York Chamber
Source: pharmiweb.com